NDC 0078-1007 – Kesimpta
Ofatumumab 20 mg/.4mL · Injection, Solution · Subcutaneous
Product NDC0078-1007
Product details
- Brand name
- Kesimpta
- Generic name
- Ofatumumab
- Labeler
- Novartis Pharmaceuticals Corporation
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA125326
- Marketed since
- October 26, 2009
- Listing expires
- December 31, 2027
- Pharmacologic class
- CD20-directed Cytolytic Antibody
Active ingredients
- Ofatumumab 20 mg/.4mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0078-1007-68 | 1 SYRINGE, GLASS in 1 CARTON (0078-1007-68) / .4 mL in 1 SYRINGE, GLASS | Aug 20, 2020 |
| 0078-1007-98 sample | 1 SYRINGE, GLASS in 1 CARTON (0078-1007-98) / .4 mL in 1 SYRINGE, GLASS | Aug 20, 2020 |